David has developed an extensive intellectual property law practice representing a wide spectrum of clientele from start-ups to Fortune 500 corporations in intellectual rights procurement, product development, handling transactions and strategic litigation.
David counsels clients in complex intellectual property matters and supervises due diligence and positioning reviews for licensing, mergers and acquisition and strategic product development, all with the result of building and enhancing value of clients’ intellectual property estates.
Augme Technologies, Inc. v. AOL, et. al.
Augme Technologies, Inc. v. YAHOO!
LAM Research, Inc. v. Xycarb Ceramics and Schunk Semiconductor
Midwest Canvas v. NTI
Ingenix v. Symmetry Health Data Systems, Inc.
Since graduating law school in 1984 from the Illinois Institute of Technology with honors (Chicago-Kent College of Law), He is admitted to practice in Arizona, Illinois, in several federal trial and appellate courts, as well as the United States Patent and Trademark Office.
An active member of multiple bar and industry associations, David serves as a member of committees on biotechnology law and university patents, and has been a featured speaker at national legal and industry conferences.
BA in General Science-Chemistry
Ph.D. in Pharmacology and Toxicology
Adjunct Professor, L.L.M. Program in Intellectual Property Law
Anthony Robbins Platinum Partner
David regularly attends and participates in intensive personal and business development programs to enhance even more his leadership of the Firm and connection with clients.
Bestseller of “Layman’s Law Guide to Patents, Trademarks, and Copyrights”
Editor at Intellectual Property Owners Association (IPO) Law Journal